It’s Time for CDMOs to Embrace the CRISPR Advantage
BioPharm International,
CDMOs are actively exploring and leveraging both new and existing technologies to streamline the cell-line development process…
CDMOs are actively exploring and leveraging both new and existing technologies to streamline the cell-line development process…
INTRODUCTION Biologic production is accelerating, with an increasing number of these essential treatments reaching the market…
https://www.alamy.com At BPI Europe in April 2019, Dirk Gewert (business unit leader of bioproduction at Horizon Discovery…